Although breast cancers in BRCA1/2 GPV carriers are more often triple-negative and have a higher histologic grade when diagnosed at a younger age [25,26,27], we did not find a difference in hormone receptor status or tumor grade pre- or post-RRSO. This evidence concerns the gene NR4A1 and neoplasm.